ARTIFICIAL TEARS SOLUTION
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded a delivery order to DMS PHARMACEUTICAL GROUP INC under contract SPE2DX25D9822, with the individual award issued as SPE2D226F2975 on July 8, 2026. The total contract value is $39.60, specifically for the procurement of ARTIFICIAL TEARS SOLUTION identified by NSN 6505009617486 and PR 7017426408. This transaction is classified as a federal award with no set-aside designation and was processed through the DIBBS system. The awardee, identified by CAGE code 1UNB0, is delivering a single line item of medical supply intended for military or defense medical use, with no specific delivery location or point of contact detailed in the contract data. The award reflects a low-value, single-item procurement typical of routine medical stock replenishment within the Department of Defense supply chain.
General Info
Contract Value
$0Place of Performance
IL, USASet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
